dodecaneperoxoic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机碳酸及其衍生物
• 英文名称: dodecaneperoxoic acid
• 英文别名: Undecyl hydrogen carbonate
• 化学式: C₁₂H₂₄O₃
• 分子量: 216.321
• InChiKey: YDHUJZYBNAPVOE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  15
• 可旋转键数：
  11
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.92
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  十二烷醇 在 Iron(III) nitrate nonahydrate 、 2,2,6,6-四甲基哌啶氧化物 、 rubidium chloride 、 氧气 作用下， 以 1,2-二氯乙烷 为溶剂， 反应 16.0h， 生成 dodecaneperoxoic acid
  参考文献：
  名称：

  醇类室温好氧氧化制羧酸的铁催化

  摘要：

  从醇氧化为羧酸，这是日常生活、学术实验室和工业中的一类基本化学品，是一种基本反应，通常使用至少化学计量量的昂贵且有毒的氧化剂。在这里，已经开发出一种使用纯 O2 甚至空气中的 O2 作为氧化剂将醇类可持续氧化为羧酸的高效实用技术：利用催化量的 Fe(NO3)3·9H2O/TEMPO/MCl，一系列在室温下从醇（也包括醛）中以高产率获得羧酸。使用空气证明了 55 克规模的反应。作为合成应用，完成了天然存在的丙二烯，即韧皮酸的首次全合成。

  DOI：

  10.1021/jacs.6b03948

文献信息

• Stable odorant systems
  申请人：Loughnane Joseph Brian

  公开号：US20070123440A1

  公开（公告）日：2007-05-31

  This invention relates to stable odorant systems, compositions comprising such systems and processes for making and using such systems and compositions.

  本发明涉及稳定的香味剂系统、包含此类系统的组合物、制备和使用此类系统和组合物的方法。
• STABLE ODORANT SYSTEMS
  申请人：Loughnane Brian Joseph

  公开号：US20110041259A1

  公开（公告）日：2011-02-24

  This invention relates to stable odorant systems, compositions comprising such systems, and processes for making and using such systems and compositions.

  本发明涉及稳定的气味剂系统，包括这些系统的组成物和制备和使用这些系统和组成物的方法。
• N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound
  申请人：Shinohata Masaaki

  公开号：US20110133121A1

  公开（公告）日：2011-06-09

  The present invention is a method for producing an N-substituted carbamic acid ester derived from an organic amine from an organic amine, a carbonic acid derivative and a hydroxy composition containing one or more types of hydroxy compounds, wherein the organic amine, the carbonic acid derivative and the hydroxy composition are reacted using a urethane production reaction vessel provided with a condenser, a gas containing the hydroxy composition, the compound having the carbonyl group derived from the carbonic acid derivative, and an ammonia formed as a by-product in the reaction, is introduced into the condenser provided in the urethane production reaction vessel, and the hydroxy composition and the compound having the carbonyl group derived from the carbonic acid derivative are condensed, and wherein a stoichiometric ratio of a hydroxy compound contained in the condensed hydroxy composition to the condensed compound having the carbonyl group derived from the carbonic acid derivative is 1 or more, and a ratio of number of carbonyl groups (—C(═O)—) contained in the compound having the carbonyl group derived from the carbonic acid derivative and number of ammonia molecules contained in the ammonia recovered as a gas from the condenser is 1 or less.

  本发明涉及一种从有机胺、碳酸衍生物和含有一种或多种羟基化合物中制得的N-取代氨基甲酸酯的制备方法，其中使用一种含有冷凝器的脲类生产反应容器反应有机胺、碳酸衍生物和羟基化合物，将含有羟基化合物的气体、来自碳酸衍生物衍生的含有羰基基团的化合物、以及在反应中形成的氨气体引入到脲类生产反应容器中的冷凝器中，使羟基化合物和含有羰基基团的化合物冷凝，其中在冷凝的羟基化合物中所含有的羟基化合物与冷凝的含有羰基基团的化合物中所含有的羰基基团的化合物的比例为1或更多，而且在从冷凝器中回收的氨气体中所含有的羰基基团（—C(═O)—）数与氨分子数的比例为1或更少。
• N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, and Composition for Transfer and Storage of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound
  申请人：Asahi Kasei Chemicals Corporation

  公开号：US20140194650A1

  公开（公告）日：2014-07-10

  The present invention is a method for producing an N-substituted carbamic acid ester derived from an organic amine from an organic amine, a carbonic acid derivative and a hydroxy composition containing one or more types of hydroxy compounds, wherein the organic amine, the carbonic acid derivative and the hydroxy composition are reacted using a urethane production reaction vessel provided with a condenser, a gas containing the hydroxy composition, the compound having the carbonyl group derived from the carbonic acid derivative, and an ammonia formed as a by-product in the reaction, is introduced into the condenser provided in the urethane production reaction vessel, and the hydroxy composition and the compound having the carbonyl group derived from the carbonic acid derivative are condensed, and wherein a stoichiometric ratio of a hydroxy compound contained in the condensed hydroxy composition to the condensed compound having the carbonyl group derived from the carbonic acid derivative is 1 or more, and a ratio of number of carbonyl groups (—C(═O)—) contained in the compound having the carbonyl group derived from the carbonic acid derivative and number of ammonia molecules contained in the ammonia recovered as a gas from the condenser is 1 or less.

  本发明是一种从有机胺、碳酸酯衍生物和含有一种或多种羟基化合物中制备N-取代的氨基甲酸酯的方法，其中利用一种尿素生产反应容器反应有机胺、碳酸酯衍生物和羟基化合物，该反应容器配有冷凝器，将含有羟基化合物的气体、由碳酸酯衍生物产生的含有羰基基团的化合物以及在反应中生成的氨引入到尿素生产反应容器中的冷凝器中，将羟基化合物和含有羰基基团的碳酸酯衍生物冷凝，其中在冷凝的羟基化合物中所含的羟基化合物的化学计量比与所冷凝的含有羰基基团的化合物的化学计量比为1或更多，而且所含有羰基基团的化合物中所含的羰基基团（-C(═O)-）的数量与从冷凝器中回收的氨分子数量的比率为1或更小。
• Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses
  申请人：SANKYO COMPANY LIMITED

  公开号：EP0790235A1

  公开（公告）日：1997-08-20

  Compounds of formula (I): [in which: R1 represents a saturated heterocyclic group attached to the bond or group represented by A through a ring carbon atom; R2a, R2b, R2c, R3a, R3b, R3c and R3d are hydrogen or various other groups or atoms; and A represents a single bond or an alkylene group having from 1 to 6 carbon atoms] are serotonin 2 receptor antagonists and have the ability to inhibit the activity of squalene synthase. They can not only prevent and inhibit the development and progression of arteriosclerosis but can also inhibit thrombosis in arteriosclerotic lesions and can improve hemodynamics.

  式(I)化合物： 其中R1代表通过环碳原子连接到 A 所代表的键或基团上的饱和杂环基团；R2a、R2b、R2c、R3a、R3b、R3c 和 R3d 是氢或各种其他基团或原子；A 代表单键或具有 1 至 6 个碳原子的亚烷基]是血清素 2 受体拮抗剂，具有抑制角鲨烯合成酶活性的能力。它们不仅能预防和抑制动脉硬化的发生和发展，还能抑制动脉硬化病变部位的血栓形成，并能改善血液动力学。